Zdrowie i gospodarka · 17/06/2020

FDA Releases Revised Guidance on Reducing HIV Risk in Blood and Blood Products

The Food and Drug Administration (FDA) has released a revised guidance document titled "Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products; Guidance for Industry," which provides updated donor deferral recommendations for blood establishments to reduce the risk of HIV transmission. The revised guidance supersedes the 2015 version and includes recommendations for donor educational materials, history questionnaires, and product management procedures.